日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cytoplasmic and nuclear protein interaction networks of the synapto-nuclear messenger CRTC1 in neurons reveal cooperative chromatin binding between CREB1 and CRTC1, MEF2C and RFX3.

神经元中突触核信使 CRTC1 的细胞质和核蛋白相互作用网络揭示了 CREB1 和 CRTC1、MEF2C 和 RFX3 之间的协同染色质结合

Neumann Sylvia, Achiro Jennifer M, Watanabe Marika, Bonnano Shivan L, Deng Weixian, Wohlschlegel James A, Martin Kelsey C

Irreversible Intrathecal Chemotherapy-induced Myelopathy in a Patient with Diffuse Large B-cell Lymphoma

弥漫性大B细胞淋巴瘤患者发生不可逆鞘内化疗诱发的脊髓病

Hirakawa, Yuri; Kitao, Akihito; Watanabe, Marika; Matsumoto, Sakuya; Komaki, Ryohei; Sakai, Rina; Morimoto, Kohei; Yakushijin, Kimikazu; Minami, Hironobu

Global longitudinal strain is superior to ejection fraction for long-term follow-up after allogeneic hematopoietic stem cell transplantation

对于异基因造血干细胞移植后的长期随访,整体纵向应变优于射血分数。

Watanabe, Marika; Yakushijin, Kimikazu; Tanaka, Hidekazu; Chijiki, Ruri; Saeki, Miki; Hirakawa, Yuri; Takakura, Hidetomo; Usui, Yutaro; Ichikawa, Hiroya; Sakai, Rina; Matsumoto, Sakuya; Nagao, Shigeki; Mizutani, Yu; Kurata, Keiji; Kitao, Akihito; Miyata, Yoshiharu; Saito, Yasuyuki; Kawamoto, Shinichiro; Yamamoto, Katsuya; Ito, Mitsuhiro; Matsuoka, Hiroshi; Minami, Hironobu

Biclonal Diffuse Large B-cell Lymphoma Commonly Characterized by Partial Trisomy 18q Involving MALT1 and BCL2

双克隆弥漫性大B细胞淋巴瘤通常以18q部分三体为特征,累及MALT1和BCL2基因。

Yamamoto, Katsuya; Kawamoto, Shinichiro; Chijiki, Ruri; Watanabe, Marika; Matsumoto, Sakuya; Kitao, Akihito; Mizutani, Yu; Kajimoto, Kazuyoshi; Hayashi, Yoshitake; Yakushijin, Kimikazu; Minami, Hironobu

Efficacy and Safety of Synbiotics in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Randomized, Double-blinded, Placebo-controlled Pilot Study

自体造血干细胞移植患者服用合生元的疗效和安全性:一项随机、双盲、安慰剂对照的初步研究

Mizutani, Yu; Kawamoto, Shinichiro; Takahashi, Michiko; Doi, Hisayo; Wakida, Kumiko; Tabuchi, Satoko; Tanda, Masaaki; Soga, Akihiro; Chijiki, Ruri; Takakura, Hidetomo; Kawaguchi, Koji; Higashime, Ako; Watanabe, Marika; Ichikawa, Hiroya; Matsumoto, Sakuya; Sakai, Rina; Goto, Hideaki; Kurata, Keiji; Kakiuchi, Seiji; Miyata, Yoshiharu; Uryu, Kiyoaki; Inui, Yumiko; Kitao, Akihito; Yakushijin, Kimikazu; Matsuoka, Hiroshi; Minami, Hironobu

Ninjinyoeito Prevents Onset of Depression-Like Behavior and Reduces Hippocampal iNOS Expression in Senescence-Accelerated Mouse Prone 8 Mice

忍饥挨饿汤可预防抑郁样行为的发生并降低衰老加速小鼠 8 型小鼠海马 iNOS 表达

Chise Taniguchi, Takuya Watanabe, Marika Hirata, Akinobu Hatae, Kaori Kubota, Shutaro Katsurabayashi, Katsunori Iwasaki

Safety and Accuracy of Professional Continuous Glucose Monitoring in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

异基因造血干细胞移植患者专业连续血糖监测的安全性和准确性

Nagao, Shigeki; Yakushijin, Kimikazu; Higashime, Ako; Kawaguchi, Koji; Watanabe, Marika; Sakai, Rina; Ichikawa, Hiroya; Mizutani, Yu; Goto, Hideaki; Kakiuchi, Seiji; Kurata, Keiji; Kitao, Akihito; Miyata, Yoshiharu; Imamura, Yoshinori; Hirota, Yushi; Takahashi, Michiko; Kawamoto, Shinichiro; Yamamoto, Katsuya; Matsuoka, Hiroshi; Minami, Hironobu

Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination

对接受抗CD20抗体治疗且两剂疫苗接种失败的患者,第三剂mRNA SARS-CoV-2疫苗显示出良好的疗效

Funakoshi, Yohei; Yakushijin, Kimikazu; Ohji, Goh; Hojo, Wataru; Sakai, Hironori; Watanabe, Marika; Kitao, Akihito; Miyata, Yoshiharu; Saito, Yasuyuki; Kawamoto, Shinichiro; Yamamoto, Katsuya; Ito, Mitsuhiro; Koyama, Taiji; Imamura, Yoshinori; Kiyota, Naomi; Matsuoka, Hiroshi; Mori, Yasuko; Minami, Hironobu

A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Patients

异基因造血干细胞移植患者接种第三剂新冠疫苗

Watanabe, Marika; Yakushijin, Kimikazu; Funakoshi, Yohei; Ohji, Goh; Ichikawa, Hiroya; Sakai, Hironori; Hojo, Wataru; Saeki, Miki; Hirakawa, Yuri; Matsumoto, Sakuya; Sakai, Rina; Nagao, Shigeki; Kitao, Akihito; Miyata, Yoshiharu; Koyama, Taiji; Saito, Yasuyuki; Kawamoto, Shinichiro; Yamamoto, Katsuya; Ito, Mitsuhiro; Murayama, Tohru; Matsuoka, Hiroshi; Minami, Hironobu

Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody

在接种mRNA SARS-CoV-2疫苗后,抗CD20抗体最后一剂注射后3年多时间,抗体滴度增加有限。

Funakoshi, Yohei; Yakushijin, Kimikazu; Ohji, Goh; Hojo, Wataru; Sakai, Hironori; Watanabe, Marika; Saeki, Miki; Hirakawa, Yuri; Sakai, Rina; Matsumoto, Sakuya; Mizutani, Yu; Kitao, Akihito; Miyata, Yoshiharu; Saito, Yasuyuki; Kawamoto, Shinichiro; Yamamoto, Katsuya; Ito, Mitsuhiro; Nishimura, Meiko; Imamura, Yoshinori; Kiyota, Naomi; Matsuoka, Hiroshi; Mori, Yasuko; Minami, Hironobu